Technical Articles

P53 突变:从守护者到失守,如何改写肿瘤治疗叙事?
P53 in Biopharma: From a 40-Year Drug Hunt to Reagent Standardization
发布时间 2026-10-10
Why P53 has driven four decades of drug discovery yet remains unsolved, and how standardized recombinant P53 reagents support target validation, screening and mechanistic studies across the industry.
View details
  • Cancer
  • P53
  • TP53 drug discovery
  • targeted therapy
  • PROTAC
  • reagent standardization
  • UA085067
P53 重组蛋白:做 DNA 损伤研究时,为何它是绕不开的标准抗原?
P53 Research Reagents: How to Choose and Use Recombinant P53 Protein
发布时间 2026-10-10
A practical guide to recombinant P53 protein as a research reagent: tag format, purification, activity validation, and how to design DNA-binding, reporter and mutant-comparison experiments around P53.
View details
  • Cancer
  • P53 protein
  • recombinant P53
  • His tag
  • DNA-binding assay
  • reporter assay
  • mutant control
  • UA085067
P53:为何被称为基因组的守护者,又如何成为肿瘤治疗的难题?
P53: Guardian of the Genome and a Persistent Challenge in Cancer Therapy
发布时间 2026-10-10
P53 (TP53) is the most studied tumor suppressor. This article breaks down its domain architecture, stress-activation mechanism, hotspot mutation spectrum, and the functional readouts and experimental interfaces commonly used in tumor research.
View details
  • Cancer
  • P53
  • TP53
  • tumor suppressor
  • DNA damage
  • DNA-binding domain
  • hotspot mutation
  • MDM2
  • apoptosis
  • UA085067
Total 3
  • 1
Go to